An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

Our gut is the key to much of our body's overall health, which is why diseases like ulcerative colitis can be so detrimental. Ulcerative colitis is one of the most common inflammatory bowel diseases.

Switching UC treatments while managing a career and home life can be a major challenge. Here’s how to navigate work logistics ...

Ulcerative Colitis Market grows at 5.4% CAGR (2025–2033), reaching US$ 12.79 Billion on rising biologic adoption, biosimilars, and personalized IBD therapies. North America leads the ulcerative ...

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...

Doctors usually prescribe antibiotics for certain types of colitis, such as ulcerative colitis and ischemic colitis. While antibiotics help with symptoms, there may be some adverse effects. Colitis ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

Here's what colitis is, what leads to it and how the condition is most commonly treated.

Microscopic colitis is a lifelong condition that causes symptoms such as diarrhea and abdominal pain. It is a type of inflammatory bowel disease (IBD). While there is no cure for microscopic colitis, ...

Researchers have used advanced genetic sequencing on a Brisbane family to identify a gene mutation linked to ulcerative colitis, a type of inflammatory bowel condition, sparking hopes of new ...